tanshinone has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gajendran, B; Han, M; Hu, Q; Lu, D; Shen, X; Wang, S; Wu, S; Xu, Y; Zhang, J | 1 |
1 other study(ies) available for tanshinone and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Tanshinone IIA ameliorates experimental diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress in cardiomyocytes via SIRT1.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Mice; Myocytes, Cardiac; Sirtuin 1 | 2023 |